CRSP logo

CRISPR Therapeutics AG (CRSP) Enterprise Value

Enterprise Value:

$4.13B-$183.72M(-4.26%)
November 3, 2025

Summary

  • As of today, CRSP enterprise value is $4.13 billion, with a fall of -$183.72 million (-4.26%) during the most recent trading session on November 3, 2025.
  • Over the past year, CRSP enterprise value has increased by +$1.50 billion (+57.25%).
  • CRSP enterprise value is now -70.30% below its all-time high of $13.90 billion.

Performance

CRSP Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherCRSPvaluation metrics

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

CRSP Enterprise Value Trends

PeriodPeriodEnterprise ValueEnterprise ValueMarket CapMarket CapPricePrice
1D1 Day-4.3%-3.2%-3.2%
1M1 Month-11.3%-8.5%-8.5%
3M3 Months+14.9%+10.5%+10.5%
6M6 Months+148.0%+70.6%+62.0%
YTDYTD+143.5%+67.0%+57.4%
1Y1 Year+57.3%+30.1%+22.1%
5Y5 Years-14.3%-8.1%-28.6%

CRSP Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month$5.47B-24.6%$4.05B+1.9%
3M3-Month$5.47B-24.6%$3.20B+28.9%
6M6-Month$5.47B-24.6%$1.22B+237.1%
1Y1-Year$5.47B-24.6%$1.06B+288.9%
3Y3-Year$6.05B-31.8%$1.06B+288.9%
5Y5-Year$13.90B-70.3%$1.06B+288.9%
All-TimeAll-Time$13.90B-70.3%$256M+1512.7%

CRSP Enterprise Value History

DateValue
2025
$4.13B(+143.5%)
2024
$1.69B(-52.3%)
2023
$3.56B(+119.5%)
2022
$1.62B(-56.0%)
2021
$3.68B(-62.0%)
DateValue
2020
$9.69B(+244.7%)
2019
$2.81B(+174.3%)
2018
$1.02B(+43.7%)
2017
$713.35M(+45.8%)
2016
$489.20M

FAQ

  • What is CRISPR Therapeutics AG enterprise value?
  • What is the all-time high enterprise value for CRISPR Therapeutics AG?
  • What is CRSP enterprise value year-to-date change?
  • What is CRISPR Therapeutics AG enterprise value year-on-year change?

What is CRISPR Therapeutics AG enterprise value?

The current enterprise value of CRSP is $4.13B

What is the all-time high enterprise value for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high enterprise value is $13.90B

What is CRSP enterprise value year-to-date change?

CRISPR Therapeutics AG enterprise value has changed by +$2.43B (+143.52%) since the beginning of the year

What is CRISPR Therapeutics AG enterprise value year-on-year change?

Over the past year, CRSP enterprise value has changed by +$1.50B (+57.25%)
On this page